Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07333.x/fullpdf
Reference10 articles.
1. Rituximab as treatment for minimal residual disease in hairy cell leukaemia;Cervetti;European Journal of Haematology,2004
2. Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia;Hagberg;British Journal of Haematology,2001
3. Bone marrow remission of hairy cell leukaemia induced by Rituximab (anti-C20 monoclonal antibody) in a patient refractory to cladribrine;Hoffman;British Journal of Haematology,2000
4. The mechanism of action of Rituximab in the elimination of tumor cells;Johnson;Seminars in Oncology,2003
5. Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine;Juliusson;Blood,1994
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues;Blood Reviews;2022-01
2. Hairy Cell Leukemia;Abeloff's Clinical Oncology;2020
3. Response to the Therapy in Hairy Cell Leukemia: Systematic Review and Meta-Analysis;Clinical Lymphoma Myeloma and Leukemia;2018-06
4. Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia?;British Journal of Haematology;2017-08-18
5. How I manage patients with hairy cell leukaemia;British Journal of Haematology;2017-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3